Next, we analyzed patients' survival and found that low expression of ABCC4 indicated better overall survial for prostate cancer patients both in TCGA database and in our own Tongji Cohort (Figure 1D and 1E). This evidence concerns the gene ABCC4 and prostate carcinoma.